Viva Biotech Holdings (HKEX: 1873) was successfully listed on the Main Board of the Stock Exchange of Hong Kong Limited. Sidley was the Hong Kong and United States legal counsel to China International Capital Corporation Hong Kong Securities Limited as sole sponsor and to China International Capital Corporation Hong Kong Securities Limited, J.P. Morgan Securities (Asia Pacific) Limited, Nomura International (Hong Kong) Limited, BOCI Asia Limited, China Renaissance Securities (Hong Kong) Limited, Haitong International Securities Company Limited, Daiwa Capital Markets Hong Kong Limited and First Shanghai Securities Limited as underwriters. The global offering raised approximately HK$1.52 billion (approximately US$195 million).
Viva Biotech Holdings is a leading open-access and innovation-driven technology platform company, and it has become a cradle for promising biotechnology companies through its innovative and unique business model.
The Sidley team was led by partners Mengyu Lu and Kefei Li, with support from associate Samantha Peng, legal manager Ashlee Wu, China advisor Rock Liu, and legal assistants Eason Qu, Junyi Li and Meiyi Li.
Sidley leads the Hong Kong legal adviser league table on deal counts for Q1 2019.*
*RyanBen Capital data (January to April 2019).